Applies to benralizumab: parenteral injection.

Side effects include:

Common adverse effects (≥5%): headache, pharyngitis.

For Healthcare Professionals

Applies to benralizumab: subcutaneous solution.

Hypersensitivity

Frequency not reported: Anaphylaxis, angioedema^[Ref]

Immunologic

Frequency not reported: Immunogenicity^[Ref]

Local

Common (1% to 10%): Injection site reactions (e.g., pain, erythema, pruritus, papule)^[Ref]

Respiratory

Common (1% to 10%): Pharyngitis (bacterial, viral, or streptococcal), cough^[Ref]

Other

Common (1% to 10%): Pyrexia^[Ref]

Nervous system

Common (1% to 10%): Headache^[Ref]

Dermatologic

Common (1% to 10%): Urticaria, rash^[Ref]